ArticleJournal of thoracic disease2023

Immune checkpoint inhibitors beyond first-line progression with prior immunotherapy in patients with advanced non-small cell lung cancer.

Manyi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.